Jan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apple, Murphy USA and UnitedHealth on Tuesday.
HIGHLIGHTS
* Apple Inc : Jefferies cuts to underperform from hold
* Caseys General Stores Inc : RBC raises target price to $430 from $428
* Mondelez : Jefferies cuts to hold from buy; cuts target price to $62 from $75
* Murphy USA Inc : RBC raises target price to $550 from $540
* UnitedHealth : Jefferies cuts target price to $609 from $635
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Alcoa Corp : HSBC cuts target price to $43 from $45
* APA Corporation : Jefferies raises target price to $26 from $23
* Apple Inc : Jefferies cuts to underperform from hold
* Apple Inc : Jefferies cuts target price to $200.75 from $211.84
* Avidity Biosciences Inc : Leerink Partners cuts target price to $60 from $64
* Berry Corporation (Bry) : Jefferies raises target price to $5 from $4.7
* Caseys General Stores Inc : RBC raises target price to $430 from $428
* Chord Energy Corp : Jefferies cuts target price to $143 from $152
* Citizens Financial : KBW raises target price to $56 from $53
* Civitas Resources Inc : Jefferies cuts target price to $73 from $78
* Conocophillips : Jefferies raises target price to $148 from $146
* Devon Energy Corp : Jefferies cuts target price to $43 from $44
* Hershey : Jefferies cuts target price to $134 from $150
* Hess : Jefferies raises target price to $165 from $151
* Huntington Bancshares Inc : D.A. Davidson cuts target price to $20.5 from $21.5
* Independent Bank Corp (Massachusetts) : KBW cuts target price to $80 from $82
* Jamf Holding Corp : RBC cuts target price to $19 from $23
* Mondelez : Jefferies cuts to hold from buy; cuts target price to $62 from $75
* Murphy USA Inc : RBC raises target price to $550 from $540
* N-Able Inc : RBC cuts target price to $12 from $15
* Nextera Energy Partners LP : CIBC cuts target price to $20 from $21
* Occidental Petroleum Corp : Jefferies raises target price to $54 from $52
* Praxis Precision Medicines : Truist Securities raises target to $175 from $150
* PTC Therapeutics Inc : Leerink Partners cuts target price to $45 from $50
* Sarepta Therapeutics Inc : Leerink Partners cuts target price to $200 from $210
* Solarwinds Corp : RBC raises target price to $16 from $13
* Ternium : HSBC cuts target price to $43 from $48
* Truist Financial Corp : KBW raises target price to $57 from $55
* Ultragenyx Pharmaceutical Inc : Leerink Partners raises target to $90 from $85
* UnitedHealth : Jefferies cuts target price to $609 from $635
* WaFd Inc : KBW cuts target price to $34 from $42
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.